Company intelligence / Profile preview

Applied DNA Clinical Labs

Stony Brook, New York, United States

Ownership: Private
Development stage: Other

Overview

Applied DNA Clinical Labs (ADCL) was a NYSDOH CLEP-permitted, CLIA-certified laboratory specializing in high-complexity testing, offering a commercially approved pharmacogenomics (PGx) test (TR8 PGx) for precision prescribing and laboratory-developed testing for Mpox (monkeypox) Clade I and II. The lab ceased operations on June 27, 2025 as part of strategic restructuring to focus on synthetic DNA manufacturing.

Therapeutic areas: CardiovascularNeurologyInfectious DiseasesPsychiatryOncology
Modalities: Diagnostic testPharmacogenomicsMolecular diagnostics
Industry: Molecular Diagnostics

Partnerships

GenXys Health Care Systems (for PGx clinical decision support software)

Beyond the preview

Go deeper on Applied DNA Clinical Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Applied DNA Clinical Labs.

Explore the full profile